Analysen von Richard Vosser
| 23.10.26 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 23.10.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 22.10.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 22.10.26 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 21.10.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.10.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 16.10.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 12.10.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 12.10.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 07.10.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 05.10.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 01.10.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 01.10.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 29.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.09.26 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 28.09.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 22.09.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 21.09.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 16.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.09.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 03.09.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 01.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.08.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 17.08.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.08.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 06.08.26 | arGEN-X Overweight | JP Morgan Chase & Co. | |
| 05.08.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 04.08.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 03.08.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.07.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 31.07.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 27.07.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.07.26 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 24.07.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 24.07.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 22.07.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 21.07.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 20.07.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 17.07.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 14.07.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.07.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.07.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 06.07.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.06.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 25.06.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 22.06.26 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |